G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer. It is also developing trilaciclib, a (CDK) 4/6 inhibitor that is in Phase III clinical trials for patients with first line colorectal cancer; Phase III clinical trial for the treatment of first line triple negative breast cancer; Phase II clinical trial for patients with first line bladder cancer; Phase II clinical trial for patients with combination with the antibody-drug conjugate; and Phase II clinical trial for the treatment of neoadjuvant breast cancer. In addition, the company develops lerociclib, an oral CDK4/6 inhibitor for multiple oncology indications; and rintodestrant, an oral selective estrogen receptor degrader, which is in Phase IIa clinical trials for the treatment of estrogen receptor-positive and HER2-negative breast cancer. The company has a license agreement with EQRx, Inc. and Genor Biopharma Co. Inc. for the development and commercialization of lerociclib using an oral dosage form to treat any indication in humans, as well as Nanjing Simcere Dongyuan Pharmaceutical Co., LTD. for the development and commercialization of trilaciclib for any indication in humans through parenteral delivery, and ARC Therapeutics for the development and commercialization of a CDK2 inhibitor for all human and veterinary uses. G1 Therapeutics, Inc. was incorporated in 2008 and is headquartered in Research Triangle Park, North Carolina. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of G1 Therapeutics Inc..
G1 Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of G1 Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of G1 Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of G1 Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of G1 Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of G1 Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 G1 Therapeutics Inc.- Key Facts
2.2 G1 Therapeutics Inc.- Geographic Locations
2.3 G1 Therapeutics Inc.- Subsidiaries and Affiliates
2.4 G1 Therapeutics Inc.- Business Divisions
2.5 G1 Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. G1 Therapeutics Inc. Strategic Analysis Review
3.1 G1 Therapeutics Inc.- Key Strategies
3.2 G1 Therapeutics Inc.- Company Outlook Statement
3.3 G1 Therapeutics Inc.- SWOT Analysis
3.3.1 G1 Therapeutics Inc.- Key Strengths
3.3.2 G1 Therapeutics Inc.- Key Weaknesses
3.3.3 G1 Therapeutics Inc.- Potential Opportunities
3.3.4 G1 Therapeutics Inc.- Potential Threats
3.4 G1 Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 G1 Therapeutics Inc.- Business Overview
4.2 G1 Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 G1 Therapeutics Inc.- Key Products
5.2 G1 Therapeutics Inc.- Key Service Areas
5.3 G1 Therapeutics Inc.- Key Brands
6 Company Developments
6.1 G1 Therapeutics Inc.- Company History
6.2 G1 Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 G1 Therapeutics Inc.- Income Statements
7.2 G1 Therapeutics Inc.- Balance Sheet
7.3 G1 Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 G1 Therapeutics Inc.- Direct Competitors
8.2 G1 Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 G1 Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 G1 Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
